These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

749 related articles for article (PubMed ID: 1908148)

  • 1. OKT3 F(ab')2 fragments--retention of the immunosuppressive properties of whole antibody with marked reduction in T cell activation and lymphokine release.
    Woodle ES; Thistlethwaite JR; Ghobrial IA; Jolliffe LK; Stuart FP; Bluestone JA
    Transplantation; 1991 Aug; 52(2):354-60. PubMed ID: 1908148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential T cell hyporesponsiveness induced by in vivo administration of intact or F(ab')2 fragments of anti-CD3 monoclonal antibody. F(ab')2 fragments induce a selective T helper dysfunction.
    Hirsch R; Archibald J; Gress RE
    J Immunol; 1991 Oct; 147(7):2088-93. PubMed ID: 1833451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-CD3 F(ab')2 fragments are immunosuppressive in vivo without evoking either the strong humoral response or morbidity associated with whole mAb.
    Hirsch R; Bluestone JA; DeNenno L; Gress RE
    Transplantation; 1990 Jun; 49(6):1117-23. PubMed ID: 2141740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trispecific F(ab')3 derivatives that use cooperative signaling via the TCR/CD3 complex and CD2 to activate and redirect resting cytotoxic T cells.
    Tutt A; Stevenson GT; Glennie MJ
    J Immunol; 1991 Jul; 147(1):60-9. PubMed ID: 1675655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a single amino acid mutation on the activating and immunosuppressive properties of a "humanized" OKT3 monoclonal antibody.
    Alegre ML; Collins AM; Pulito VL; Brosius RA; Olson WC; Zivin RA; Knowles R; Thistlethwaite JR; Jolliffe LK; Bluestone JA
    J Immunol; 1992 Jun; 148(11):3461-8. PubMed ID: 1534096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of lymphokine production by distinct subunits of the T cell interleukin 2 receptor.
    Burdach S; Zessack N; Dilloo D; Shatsky M; Thompson D; Levitt L
    J Clin Invest; 1991 Jun; 87(6):2114-21. PubMed ID: 1828253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valency of CD3 binding and internalization of the CD3 cell-surface complex control T cell responses to second signals: distinction between effects on protein kinase C, cytoplasmic free calcium, and proliferation.
    Ledbetter JA; June CH; Martin PJ; Spooner CE; Hansen JA; Meier KE
    J Immunol; 1986 Jun; 136(11):3945-52. PubMed ID: 3084650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel model for antigen-dependent activation of normal human T cells. Transmembrane signaling by crosslinkage of the CD3/T cell receptor-alpha/beta complex with the cluster determinant 2 antigen.
    Suthanthiran M
    J Exp Med; 1990 Jun; 171(6):1965-79. PubMed ID: 1972176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of autoimmune diabetes with nonactivating anti-CD3 monoclonal antibody.
    Herold KC; Bluestone JA; Montag AG; Parihar A; Wiegner A; Gress RE; Hirsch R
    Diabetes; 1992 Mar; 41(3):385-91. PubMed ID: 1532369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of in vivo administration of anti-CD3 monoclonal antibody on T cell function in mice. II. In vivo activation of T cells.
    Hirsch R; Gress RE; Pluznik DH; Eckhaus M; Bluestone JA
    J Immunol; 1989 Feb; 142(3):737-43. PubMed ID: 2521507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humanized OKT3 antibodies: successful transfer of immune modulating properties and idiotype expression.
    Woodle ES; Thistlethwaite JR; Jolliffe LK; Zivin RA; Collins A; Adair JR; Bodmer M; Athwal D; Alegre ML; Bluestone JA
    J Immunol; 1992 May; 148(9):2756-63. PubMed ID: 1533410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8+ T cells lyse autologous monocytes in the presence of anti-CD3 monoclonal antibody: association with interleukin-1 production.
    Itoh K; Balch CM; Trial J; Platsoucas CD
    Cell Immunol; 1988 Jul; 114(2):257-71. PubMed ID: 3260540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mechanism of anti-CD3 monoclonal antibodies. Mediation of cytolysis by inter-T cell bridging.
    Wong JT; Eylath AA; Ghobrial I; Colvin RB
    Transplantation; 1990 Oct; 50(4):683-9. PubMed ID: 2145670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-CD3 monoclonal antibody therapy. An approach toward optimization by in vitro analysis of new anti-CD3 antibodies.
    Woodle ES; Thistlethwaite JR; Jolliffe LK; Fucello AJ; Stuart FP; Bluestone JA
    Transplantation; 1991 Aug; 52(2):361-8. PubMed ID: 1714644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OKT3 monoclonal antibody induces production of colony-stimulating factor(s) for granulocytes and macrophages in cultures of human T lymphocytes and adherent cells.
    Platzer E; Rubin BY; Lu L; Welte K; Broxmeyer HE; Moore MA
    J Immunol; 1985 Jan; 134(1):265-71. PubMed ID: 3917276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inducible expression of granulocyte-macrophage colony-stimulating factor, tumor necrosis factor-alpha, and interferon-gamma in two human cytotoxic leukemic T-cell lines.
    Cesano A; Santoli D
    In Vitro Cell Dev Biol; 1992; 28A(9-10):657-62. PubMed ID: 1429368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of suppressor cells to T- and B-cell proliferative responses and immunoglobulin production by monoclonal antibodies recognizing the CD3 T-cell differentiation antigen.
    Kunicka JE; Platsoucas CD
    Cell Immunol; 1988 Oct; 116(1):195-215. PubMed ID: 2901914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dichotomous effect of monocyte Fc receptor interaction on anti-CD3-induced immunoglobulin synthesis.
    Wyss T; Bettens F; Walker C; Pichler WJ
    Cell Immunol; 1990 Mar; 126(1):91-105. PubMed ID: 2137378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo administration of anti-murine CD3 monoclonal antibody induces selective, long-term anergy in CD8+ T cells.
    Woodle ES; Hussein S; Bluestone JA
    Transplantation; 1996 Mar; 61(5):798-803. PubMed ID: 8607186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency analysis of lymphokine-secreting CD4+ and CD8+ T cells activated in a graft-versus-host reaction.
    Kelso A
    J Immunol; 1990 Oct; 145(7):2167-76. PubMed ID: 1975827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.